Global Lisinopril Market Research Report 2020

Global Lisinopril Market Research Report 2020

Table of Contents
1 Lisinopril Market Overview
1.1 Product Overview and Scope of Lisinopril
1.2 Lisinopril Segment by Type
1.2.1 Global Lisinopril Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Lisinopril Segment by Application
1.3.1 Lisinopril Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Revenue 2015-2026
1.4.2 Global Lisinopril Sales 2015-2026
1.4.3 Lisinopril Market Size by Region: 2020 Versus 2026
2 Global Lisinopril Market Competition by Manufacturers
2.1 Global Lisinopril Sales Market Share by Manufacturers (2015-2020)
2.2 Global Lisinopril Revenue Share by Manufacturers (2015-2020)
2.3 Global Lisinopril Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Lisinopril Manufacturing Sites, Area Served, Product Type
2.5 Lisinopril Market Competitive Situation and Trends
2.5.1 Lisinopril Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Lisinopril Players (Opinion Leaders)
3 Lisinopril Retrospective Market Scenario by Region
3.1 Global Lisinopril Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Lisinopril Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Lisinopril Market Facts & Figures by Country
3.3.1 North America Lisinopril Sales by Country
3.3.2 North America Lisinopril Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Lisinopril Market Facts & Figures by Country
3.4.1 Europe Lisinopril Sales by Country
3.4.2 Europe Lisinopril Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lisinopril Market Facts & Figures by Region
3.5.1 Asia Pacific Lisinopril Sales by Region
3.5.2 Asia Pacific Lisinopril Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Lisinopril Market Facts & Figures by Country
3.6.1 Latin America Lisinopril Sales by Country
3.6.2 Latin America Lisinopril Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Lisinopril Market Facts & Figures by Country
3.7.1 Middle East and Africa Lisinopril Sales by Country
3.7.2 Middle East and Africa Lisinopril Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Lisinopril Historic Market Analysis by Type
4.1 Global Lisinopril Sales Market Share by Type (2015-2020)
4.2 Global Lisinopril Revenue Market Share by Type (2015-2020)
4.3 Global Lisinopril Price Market Share by Type (2015-2020)
4.4 Global Lisinopril Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Lisinopril Historic Market Analysis by Application
5.1 Global Lisinopril Sales Market Share by Application (2015-2020)
5.2 Global Lisinopril Revenue Market Share by Application (2015-2020)
5.3 Global Lisinopril Price by Application (2015-2020)
6 Company Profiles and Key Figures in Lisinopril Business
6.1 Actavis Elizabeth
6.1.1 Corporation Information
6.1.2 Actavis Elizabeth Description, Business Overview and Total Revenue
6.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Actavis Elizabeth Products Offered
6.1.5 Actavis Elizabeth Recent Development
6.2 Apotex
6.2.1 Apotex Lisinopril Production Sites and Area Served
6.2.2 Apotex Description, Business Overview and Total Revenue
6.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Apotex Products Offered
6.2.5 Apotex Recent Development
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Lisinopril Production Sites and Area Served
6.3.2 Aurobindo Pharma Description, Business Overview and Total Revenue
6.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Aurobindo Pharma Products Offered
6.3.5 Aurobindo Pharma Recent Development
6.4 Ivax Pharmaceuticals
6.4.1 Ivax Pharmaceuticals Lisinopril Production Sites and Area Served
6.4.2 Ivax Pharmaceuticals Description, Business Overview and Total Revenue
6.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ivax Pharmaceuticals Products Offered
6.4.5 Ivax Pharmaceuticals Recent Development
6.5 Lek Pharmaceuticals
6.5.1 Lek Pharmaceuticals Lisinopril Production Sites and Area Served
6.5.2 Lek Pharmaceuticals Description, Business Overview and Total Revenue
6.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Lek Pharmaceuticals Products Offered
6.5.5 Lek Pharmaceuticals Recent Development
6.6 Lupin
6.6.1 Lupin Lisinopril Production Sites and Area Served
6.6.2 Lupin Description, Business Overview and Total Revenue
6.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Lupin Products Offered
6.6.5 Lupin Recent Development
6.7 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Lisinopril Production Sites and Area Served
6.6.2 Mylan Pharmaceuticals Description, Business Overview and Total Revenue
6.6.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Mylan Pharmaceuticals Products Offered
6.7.5 Mylan Pharmaceuticals Recent Development
6.8 Ranbaxy Pharmaceuticals
6.8.1 Ranbaxy Pharmaceuticals Lisinopril Production Sites and Area Served
6.8.2 Ranbaxy Pharmaceuticals Description, Business Overview and Total Revenue
6.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Ranbaxy Pharmaceuticals Products Offered
6.8.5 Ranbaxy Pharmaceuticals Recent Development
6.9 Novartis
6.9.1 Novartis Lisinopril Production Sites and Area Served
6.9.2 Novartis Description, Business Overview and Total Revenue
6.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Novartis Products Offered
6.9.5 Novartis Recent Development
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Lisinopril Production Sites and Area Served
6.10.2 Teva Pharmaceuticals Description, Business Overview and Total Revenue
6.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Teva Pharmaceuticals Products Offered
6.10.5 Teva Pharmaceuticals Recent Development
6.11 Vintage Pharmaceuticals
6.11.1 Vintage Pharmaceuticals Lisinopril Production Sites and Area Served
6.11.2 Vintage Pharmaceuticals Lisinopril Description, Business Overview and Total Revenue
6.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Vintage Pharmaceuticals Products Offered
6.11.5 Vintage Pharmaceuticals Recent Development
6.12 Watson Laboratories
6.12.1 Watson Laboratories Lisinopril Production Sites and Area Served
6.12.2 Watson Laboratories Lisinopril Description, Business Overview and Total Revenue
6.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Watson Laboratories Products Offered
6.12.5 Watson Laboratories Recent Development
6.13 West Ward Pharmaceutical
6.13.1 West Ward Pharmaceutical Lisinopril Production Sites and Area Served
6.13.2 West Ward Pharmaceutical Lisinopril Description, Business Overview and Total Revenue
6.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.13.4 West Ward Pharmaceutical Products Offered
6.13.5 West Ward Pharmaceutical Recent Development
6.14 Wockhardt
6.14.1 Wockhardt Lisinopril Production Sites and Area Served
6.14.2 Wockhardt Lisinopril Description, Business Overview and Total Revenue
6.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Wockhardt Products Offered
6.14.5 Wockhardt Recent Development
6.15 Merck Research Laboratories
6.15.1 Merck Research Laboratories Lisinopril Production Sites and Area Served
6.15.2 Merck Research Laboratories Lisinopril Description, Business Overview and Total Revenue
6.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Merck Research Laboratories Products Offered
6.15.5 Merck Research Laboratories Recent Development
6.16 Astrazeneca
6.16.1 Astrazeneca Lisinopril Production Sites and Area Served
6.16.2 Astrazeneca Lisinopril Description, Business Overview and Total Revenue
6.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Astrazeneca Products Offered
6.16.5 Astrazeneca Recent Development
6.17 Alvogen
6.17.1 Alvogen Lisinopril Production Sites and Area Served
6.17.2 Alvogen Lisinopril Description, Business Overview and Total Revenue
6.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Alvogen Products Offered
6.17.5 Alvogen Recent Development
6.18 Hikma
6.18.1 Hikma Lisinopril Production Sites and Area Served
6.18.2 Hikma Lisinopril Description, Business Overview and Total Revenue
6.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Hikma Products Offered
6.18.5 Hikma Recent Development
6.19 Prinston
6.19.1 Prinston Lisinopril Production Sites and Area Served
6.19.2 Prinston Lisinopril Description, Business Overview and Total Revenue
6.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Prinston Products Offered
6.19.5 Prinston Recent Development
6.20 Accord Hlthcare
6.20.1 Accord Hlthcare Lisinopril Production Sites and Area Served
6.20.2 Accord Hlthcare Lisinopril Description, Business Overview and Total Revenue
6.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Accord Hlthcare Products Offered
6.20.5 Accord Hlthcare Recent Development
6.21 CASI Pharms
6.21.1 CASI Pharms Lisinopril Production Sites and Area Served
6.21.2 CASI Pharms Lisinopril Description, Business Overview and Total Revenue
6.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.21.4 CASI Pharms Products Offered
6.21.5 CASI Pharms Recent Development
6.22 Invagen Pharms
6.22.1 Invagen Pharms Lisinopril Production Sites and Area Served
6.22.2 Invagen Pharms Lisinopril Description, Business Overview and Total Revenue
6.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Invagen Pharms Products Offered
6.22.5 Invagen Pharms Recent Development
6.23 SUN Pharm
6.23.1 SUN Pharm Lisinopril Production Sites and Area Served
6.23.2 SUN Pharm Lisinopril Description, Business Overview and Total Revenue
6.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2015-2020)
6.23.4 SUN Pharm Products Offered
6.23.5 SUN Pharm Recent Development
7 Lisinopril Manufacturing Cost Analysis
7.1 Lisinopril Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lisinopril
7.4 Lisinopril Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lisinopril Distributors List
8.3 Lisinopril Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Lisinopril Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lisinopril by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Lisinopril by Type (2021-2026)
10.2 Lisinopril Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Lisinopril by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Lisinopril by Application (2021-2026)
10.3 Lisinopril Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lisinopril by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Lisinopril by Region (2021-2026)
10.4 North America Lisinopril Estimates and Projections (2021-2026)
10.5 Europe Lisinopril Estimates and Projections (2021-2026)
10.6 Asia Pacific Lisinopril Estimates and Projections (2021-2026)
10.7 Latin America Lisinopril Estimates and Projections (2021-2026)
10.8 Middle East and Africa Lisinopril Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Lisinopril Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Lisinopril Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Lisinopril Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Lisinopril Manufacturers Covered in This Study
Table 5. Global Lisinopril Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Lisinopril Sales Share by Manufacturers (2015-2020)
Table 7. Global Lisinopril Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Lisinopril Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Lisinopril Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Lisinopril Sales Sites and Area Served
Table 11. Manufacturers Lisinopril Product Types
Table 12. Global Lisinopril Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Lisinopril by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lisinopril as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Lisinopril Players
Table 16. Global Lisinopril Sales (K Units) by Region (2015-2020)
Table 17. Global Lisinopril Sales Market Share by Region (2015-2020)
Table 18. Global Lisinopril Revenue (Million US$) by Region (2015-2020)
Table 19. Global Lisinopril Revenue Market Share by Region (2015-2020)
Table 20. North America Lisinopril Sales by Country (2015-2020) (K Units)
Table 21. North America Lisinopril Sales Market Share by Country (2015-2020)
Table 22. North America Lisinopril Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Lisinopril Revenue Market Share by Country (2015-2020)
Table 24. Europe Lisinopril Sales by Country (2015-2020) (K Units)
Table 25. Europe Lisinopril Sales Market Share by Country (2015-2020)
Table 26. Europe Lisinopril Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Lisinopril Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Lisinopril Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Lisinopril Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Lisinopril Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Lisinopril Revenue Market Share by Region (2015-2020)
Table 32. Latin America Lisinopril Sales by Country (2015-2020) (K Units)
Table 33. Latin America Lisinopril Sales Market Share by Country (2015-2020)
Table 34. Latin America Lisinopril Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Lisinopril Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Lisinopril Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Lisinopril Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Lisinopril Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Lisinopril Revenue Market Share by Country (2015-2020)
Table 40. Global Lisinopril Sales (K Units) by Type (2015-2020)
Table 41. Global Lisinopril Sales Share by Type (2015-2020)
Table 42. Global Lisinopril Revenue (Million US$) by Type (2015-2020)
Table 43. Global Lisinopril Revenue Share by Type (2015-2020)
Table 44. Global Lisinopril Price (US$/Unit) by Type (2015-2020)
Table 45. Global Lisinopril Sales (K Units) by Application (2015-2020)
Table 46. Global Lisinopril Sales Market Share by Application (2015-2020)
Table 47. Global Lisinopril Sales Growth Rate by Application (2015-2020)
Table 48. Actavis Elizabeth Lisinopril Corporation Information
Table 49. Actavis Elizabeth Description and Business Overview
Table 50. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Actavis Elizabeth Main Product
Table 52. Actavis Elizabeth Recent Development
Table 53. Apotex Lisinopril Corporation Information
Table 54. Apotex Corporation Information
Table 55. Apotex Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Apotex Main Product
Table 57. Apotex Recent Development
Table 58. Aurobindo Pharma Lisinopril Corporation Information
Table 59. Aurobindo Pharma Corporation Information
Table 60. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Aurobindo Pharma Main Product
Table 62. Aurobindo Pharma Recent Development
Table 63. Ivax Pharmaceuticals Lisinopril Corporation Information
Table 64. Ivax Pharmaceuticals Corporation Information
Table 65. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Ivax Pharmaceuticals Main Product
Table 67. Ivax Pharmaceuticals Recent Development
Table 68. Lek Pharmaceuticals Lisinopril Corporation Information
Table 69. Lek Pharmaceuticals Corporation Information
Table 70. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Lek Pharmaceuticals Main Product
Table 72. Lek Pharmaceuticals Recent Development
Table 73. Lupin Lisinopril Corporation Information
Table 74. Lupin Corporation Information
Table 75. Lupin Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Lupin Main Product
Table 77. Lupin Recent Development
Table 78. Mylan Pharmaceuticals Lisinopril Corporation Information
Table 79. Mylan Pharmaceuticals Corporation Information
Table 80. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Mylan Pharmaceuticals Main Product
Table 82. Mylan Pharmaceuticals Recent Development
Table 83. Ranbaxy Pharmaceuticals Lisinopril Corporation Information
Table 84. Ranbaxy Pharmaceuticals Corporation Information
Table 85. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Ranbaxy Pharmaceuticals Main Product
Table 87. Ranbaxy Pharmaceuticals Recent Development
Table 88. Novartis Lisinopril Corporation Information
Table 89. Novartis Corporation Information
Table 90. Novartis Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Novartis Main Product
Table 92. Novartis Recent Development
Table 93. Teva Pharmaceuticals Lisinopril Corporation Information
Table 94. Teva Pharmaceuticals Corporation Information
Table 95. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 96. Teva Pharmaceuticals Main Product
Table 97. Teva Pharmaceuticals Recent Development
Table 98. Vintage Pharmaceuticals Lisinopril Corporation Information
Table 99. Vintage Pharmaceuticals Corporation Information
Table 100. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 101. Vintage Pharmaceuticals Main Product
Table 102. Vintage Pharmaceuticals Recent Development
Table 103. Watson Laboratories Lisinopril Corporation Information
Table 104. Watson Laboratories Corporation Information
Table 105. Watson Laboratories Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 106. Watson Laboratories Main Product
Table 107. Watson Laboratories Recent Development
Table 108. West Ward Pharmaceutical Lisinopril Corporation Information
Table 109. West Ward Pharmaceutical Corporation Information
Table 110. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 111. West Ward Pharmaceutical Main Product
Table 112. West Ward Pharmaceutical Recent Development
Table 113. Wockhardt Lisinopril Corporation Information
Table 114. Wockhardt Corporation Information
Table 115. Wockhardt Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. Wockhardt Main Product
Table 117. Wockhardt Recent Development
Table 118. Merck Research Laboratories Lisinopril Corporation Information
Table 119. Merck Research Laboratories Corporation Information
Table 120. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Merck Research Laboratories Main Product
Table 122. Merck Research Laboratories Recent Development
Table 123. Astrazeneca Lisinopril Corporation Information
Table 124. Astrazeneca Corporation Information
Table 125. Astrazeneca Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 126. Astrazeneca Main Product
Table 127. Astrazeneca Recent Development
Table 128. Alvogen Lisinopril Corporation Information
Table 129. Alvogen Corporation Information
Table 130. Alvogen Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 131. Alvogen Main Product
Table 132. Alvogen Recent Development
Table 133. Hikma Lisinopril Corporation Information
Table 134. Hikma Corporation Information
Table 135. Hikma Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 136. Hikma Main Product
Table 137. Hikma Recent Development
Table 138. Prinston Lisinopril Corporation Information
Table 139. Prinston Corporation Information
Table 140. Prinston Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 141. Prinston Main Product
Table 142. Prinston Recent Development
Table 143. Accord Hlthcare Lisinopril Corporation Information
Table 144. Accord Hlthcare Corporation Information
Table 145. Accord Hlthcare Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 146. Accord Hlthcare Main Product
Table 147. Accord Hlthcare Recent Development
Table 148. CASI Pharms Lisinopril Corporation Information
Table 149. CASI Pharms Corporation Information
Table 150. CASI Pharms Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 151. CASI Pharms Main Product
Table 152. CASI Pharms Recent Development
Table 153. Invagen Pharms Lisinopril Corporation Information
Table 154. Invagen Pharms Corporation Information
Table 155. Invagen Pharms Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 156. Invagen Pharms Main Product
Table 157. Invagen Pharms Recent Development
Table 158. SUN Pharm Lisinopril Corporation Information
Table 159. SUN Pharm Corporation Information
Table 160. SUN Pharm Lisinopril Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 161. SUN Pharm Main Product
Table 162. SUN Pharm Recent Development
Table 163. Sales Base and Market Concentration Rate of Raw Material
Table 164. Key Suppliers of Raw Materials
Table 165. Lisinopril Distributors List
Table 166. Lisinopril Customers List
Table 167. Market Key Trends
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Global Lisinopril Sales (K Units) Forecast by Type (2021-2026)
Table 171. Global Lisinopril Sales Market Share Forecast by Type (2021-2026)
Table 172. Global Lisinopril Revenue (Million US$) Forecast by Type (2021-2026)
Table 173. Global Lisinopril Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 174. Global Lisinopril Sales (K Units) Forecast by Application (2021-2026)
Table 175. Global Lisinopril Revenue (Million US$) Forecast by Application (2021-2026)
Table 176. Global Lisinopril Sales (K Units) Forecast by Region (2021-2026)
Table 177. Global Lisinopril Sales Market Share Forecast by Region (2021-2026)
Table 178. Global Lisinopril Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Global Lisinopril Revenue Market Share Forecast by Region (2021-2026)
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Lisinopril
Figure 2. Global Lisinopril Sales Market Share by Type: 2020 VS 2026
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 20mg Product Picture
Figure 7. 30mg Product Picture
Figure 8. 40mg Product Picture
Figure 9. Global Lisinopril Consumption Market Share by Application: 2020 VS 2026
Figure 10. Hospital
Figure 11. Drug Store
Figure 12. Global Lisinopril Market Size 2015-2026 (US$ Million)
Figure 13. Global Lisinopril Sales Capacity (K Units) (2015-2026)
Figure 14. Global Lisinopril Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Lisinopril Sales Share by Manufacturers in 2020
Figure 16. Global Lisinopril Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lisinopril Revenue in 2019
Figure 18. Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Lisinopril Sales Market Share by Region (2015-2020)
Figure 20. Global Lisinopril Sales Market Share by Region in 2019
Figure 21. Global Lisinopril Revenue Market Share by Region (2015-2020)
Figure 22. Global Lisinopril Revenue Market Share by Region in 2019
Figure 23. North America Lisinopril Sales Market Share by Country in 2019
Figure 24. North America Lisinopril Revenue Market Share by Country in 2019
Figure 25. U.S. Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Lisinopril Sales Market Share by Country in 2019
Figure 30. Europe Lisinopril Revenue Market Share by Country in 2019
Figure 31. Germany Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Lisinopril Sales Market Share by Region in 2019
Figure 42. Asia Pacific Lisinopril Revenue Market Share by Region in 2019
Figure 43. China Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Lisinopril Sales Market Share by Country in 2019
Figure 66. Latin America Lisinopril Revenue Market Share by Country in 2019
Figure 67. Mexico Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Lisinopril Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Lisinopril Revenue Market Share by Country in 2019
Figure 75. Turkey Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 76. Turkey Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 78. Saudi Arabia Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Lisinopril Sales Growth Rate (2015-2020) (K Units)
Figure 80. U.A.E Lisinopril Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Lisinopril by Type (2015-2020)
Figure 82. Sales Market Share of Lisinopril by Type in 2019
Figure 83. Revenue Share of Lisinopril by Type (2015-2020)
Figure 84. Revenue Market Share of Lisinopril by Type in 2019
Figure 85. Global Lisinopril Sales Growth by Type (2015-2020) (K Units)
Figure 86. Global Lisinopril Sales Market Share by Application (2015-2020)
Figure 87. Global Lisinopril Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Lisinopril by Application (2015-2020)
Figure 89. Global Revenue Share of Lisinopril by Application in 2020
Figure 90. Actavis Elizabeth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Ivax Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Lek Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Mylan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Ranbaxy Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Vintage Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Watson Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. West Ward Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Merck Research Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Alvogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Prinston Total Reven

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs